Excited to share our manuscript on TD-RDR, a novel CTO PCI technique combining some advantages of tip detection with the retrograde approach. @azeemlatib @wjn_md @leoneppmd @MontefioreNYC @JACCJournals @crfheart @SCAI #CTO101 #CTOPCI sciencedirect.com/science/ar…

Real-world operators have been leaving patients with acceptable but still less-than-optimal results after transcatheter mitral edge-to-edge repair, with some suggesting moving the goalposts for success. #NYValves2026 @azeemlatib @leoneppmd @jgranadacrf medpagetoday.com/meetingcove…

BATMAN was associated with high technical success and effectiveness in preventing #LVOT obstruction and appeared to be safe in ViR and ViV procedures. Adverse events were higher in ViMAC. jacc.org/doi/10.1016/j.jcin.… #JACCINT #TMVR

Thanks to a large collaborative effort from 27 centers worldwide, we built the #LOFTER registry, collecting leaflet modification procedures to better understand procedural dynamics and outcomes of #leaflet #modification techniques to mitigate #coronary #obstruction in #TAVR patients. We contributed to the dedicated issue on @JACCJournals, and results are available here. sciencedirect.com/science/ar… More work ahead. @AnderRegueiro

Finally out! Thank you to all the participating centers and operators!! Balloon-Assisted Translocation of the Mitral Anterior Leaflet to Prevent Outflow Tract Obstruction During TMVR: BATMAN-Registry | JACC: Cardiovascular Interventions jacc.org/doi/10.1016/j.jcin.…

Thank you for being part of an historic EPIC 2026! #epic #EmoryPercutaneousInterventionCourse

5 patients enrolled and treated today in Structural Heart trials at @MontefioreNYC , including the first 3 US patients in PARADIGM: the @AnterisTech DurAVR THV RCT. DurAVR is a biomimetic balloon-expandable valve designed to restore laminar flow in severe AS. @MonteHeart

DES following DCB-based PCI is not associated with increased stent failure at 1-year. The International Multicenter BAILOUT Registry @antoniomangieri @azeemlatib @GGStefanini @Kyhl_K @leoneppmd @vass_vassiliou @corballistash @DrPeterOKane @mauro_gitto ahajrnls.org/4emkUq3

Seize the spotlight at #NYValves2026! 💥 Submit your most challenging cases in valvular and structural heart disease for a chance to present your work on one of the biggest stages in #interventionalcardiology. 🗽🌐 Top cases will be published in JACC: Case Reports. 📅 Deadline: April 14 | 2:00 PM EDT (UTC −4) Submit now!👉 ow.ly/4jEe50YHv34 #CardioX #CardioTwitter #CardioEd #CardioResearch @Kalazizimd @bapat_savrtavr @BurkhoffMD @djc795 @npfam1 @igeorge1975 @jgranadacrf @AdamGreenbaumMD @hahn_rt @EdwinHoMD @TsuyoshiKaneko1 @SusheelKodaliMD @azeemlatib @MartyBLeon @leoneppmd @TheDoctorMack @MVMadhavanMD @jamiemccabeMD @modine_thomas @tnazifMD @PopmaJeffrey @laurenranard @MarwanSaadMD @psorajja @GilbertTangMD @drnvanmieghem @vonBardelebenRS @JennifervStein @philippvstein @PradeepYadavMD @mirvatalasnag @triciarawh @TCTConference @TCTMD @sbhci

Glad to share the last issue of @cardiacinterv covering the new directions in PCI and calcium management. Excellent work by all the authors! @PSandesara_MD @mbmcentegart @kevinjamescroce @OlgaTolevaMD @leoneppmd @TRheude @MatteoSturlaM

Together with @Antocol17 and @azeemlatib, we comment on @JACCJournals how real-time fluoroscopic assessment can uncover suboptimal valve expansion and why this may matter for long-term TAVR durability lnkd.in/ejQfNG2n lnkd.in/eQKhwXpE

Balones farmacoactivos: a la conquista de la enfermedad coronaria de vaso grande #Aheadofprint @Antocol17 @leoneppmd recintervcardiol.org/es/edit…

I am energized!! Shout out to the #TACIT directors @sjorge4 @ignamatsant @CathElectroSurg tacitmeeting.com

Tomorrow we start the second edition of TACIT Meeting - Hands-on learning in structural heart interventions ‼️ With the greatest colleagues @sjorge4 @CathElectroSurg @phillipfreeman @leoneppmd @DrArifK @MarciMonteg @AnderRegueiro tacitmeeting.com

Please join us. Greg is amazing and a radial expert!

It’s the final day of @TCTMD 2025! We have enjoyed connecting with colleagues from around the world and are looking forward to hearing these podium presentations today. 🗓️ Tuesday, October 28 8:40 AM – Computational Fluid Dynamic and Morphometric Analysis of the Novel DynamX® Bioadaptor System at Baseline and 1-Year Follow-Up (@giuliorus) 📍Presentation Theater 2 | Hall D Session: Cases with the Masters – Acute Coronary Syndromes: Vulnerable Plaque 12:00 PM – DynamX® Bioadaptor Implantation for Treatment of Complex Coronary Artery Disease – Final Results from the DYNAMITE Study (@leoneppmd) 📍Station 5 | Halls B-C Session: Scientific Abstracts – Newer Stent Design Studies 1:00 PM – 2-Year Nationwide Analysis from SWEDEHEART: Comparison of Drug-Coated Balloons and the Bioadaptor in Treatment of De Novo Coronary Lesions @DavidErlinge) 📍Station 7 | Halls B-C Session: Novel Technologies for Transcatheter Coronary Interventions #TCT2025 #Cardiology #Bioadaptor #LithiX #PCI #Innovation #ElixirMedical

Our latest piece from 🇮🇹🇺🇸🇨🇳🇪🇸challenging the automatic reliance on #DES #PCI, and advocating for drug-coated balloons #DCB where appropriate. Read more shorturl.at/MBwbE @PCVDJournal @CardioMDPhD @mauro_gitto Chao Gao @sjorge4 @azeemlatib @Antocol17 @MonteHeart

Just wrapped an incredible journey as part of the Program Development Committee for NY Valves with @gu_asc1 @philippvstein @JennifervStein! 🚀 
Innovation, insight and inspiration - #NYValves2025 delivered. Until next time! 🔧🫀 #NYValves @crfheart

Great cases and presentations from the @MonteHeart team. @EdwinHoMD @AndreaScotti21 @leoneppmd @UlrichJordeMD @m_assafin @MontefioreNYC

Do female patients respond differently than males? Higher 2-year MACE after sirolimus-coated balloon angioplasty for female patients with in-stent restenosis. A hypothesis generating research letter @Dr.LucaTesta @leoneppmd @AGrecoMD @Dari08s ahajrnls.org/4nagaWk